1. Home
  2. WVE vs BZH Comparison

WVE vs BZH Comparison

Compare WVE & BZH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • BZH
  • Stock Information
  • Founded
  • WVE 2012
  • BZH 1985
  • Country
  • WVE Singapore
  • BZH United States
  • Employees
  • WVE N/A
  • BZH N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • BZH Homebuilding
  • Sector
  • WVE Health Care
  • BZH Consumer Discretionary
  • Exchange
  • WVE Nasdaq
  • BZH Nasdaq
  • Market Cap
  • WVE 915.6M
  • BZH 780.6M
  • IPO Year
  • WVE 2015
  • BZH 1994
  • Fundamental
  • Price
  • WVE $7.79
  • BZH $21.92
  • Analyst Decision
  • WVE Strong Buy
  • BZH Strong Buy
  • Analyst Count
  • WVE 16
  • BZH 3
  • Target Price
  • WVE $20.19
  • BZH $32.00
  • AVG Volume (30 Days)
  • WVE 2.1M
  • BZH 317.7K
  • Earning Date
  • WVE 11-11-2025
  • BZH 11-12-2025
  • Dividend Yield
  • WVE N/A
  • BZH N/A
  • EPS Growth
  • WVE N/A
  • BZH N/A
  • EPS
  • WVE N/A
  • BZH 2.23
  • Revenue
  • WVE $93,946,000.00
  • BZH $2,385,816,000.00
  • Revenue This Year
  • WVE N/A
  • BZH N/A
  • Revenue Next Year
  • WVE $6.85
  • BZH $5.53
  • P/E Ratio
  • WVE N/A
  • BZH $9.82
  • Revenue Growth
  • WVE N/A
  • BZH 9.97
  • 52 Week Low
  • WVE $5.28
  • BZH $17.37
  • 52 Week High
  • WVE $16.74
  • BZH $38.22
  • Technical
  • Relative Strength Index (RSI)
  • WVE 52.90
  • BZH 29.79
  • Support Level
  • WVE $6.91
  • BZH $24.34
  • Resistance Level
  • WVE $8.31
  • BZH $25.56
  • Average True Range (ATR)
  • WVE 0.42
  • BZH 0.73
  • MACD
  • WVE 0.15
  • BZH -0.32
  • Stochastic Oscillator
  • WVE 69.65
  • BZH 8.08

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

Share on Social Networks: